Front Row Advisors LLC Charles River Laboratories International, Inc. Transaction History
Front Row Advisors LLC
- $282 Million
- Q2 2024
A detailed history of Front Row Advisors LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Front Row Advisors LLC holds 170 shares of CRL stock, worth $33,624. This represents 0.01% of its overall portfolio holdings.
Number of Shares
170
Previous 172
1.16%
Holding current value
$33,624
Previous $46,000
23.91%
% of portfolio
0.01%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding CRL
# of Institutions
722Shares Held
52.2MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1.01 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$413 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$378 Million0.99% of portfolio
-
Allspring Global Investments Holdings, LLC1.76MShares$348 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.1B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...